# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
60, Journal, 0, 28, "Nippon Ganka Gakkai Zasshi .", "", "<http://ctro/data#Publication_81108> <http://ctro/data#hasJournal> \"Nippon Ganka Gakkai Zasshi .\"."
1, PublicationYear, 29, 33, "2010", "", "<http://ctro/data#Publication_81108> <http://ctro/data#hasPublicationYear> \"2010\"."
11, Title, 65, 252, "Intraocular pressure lowering effect of 0 . 0015 % tafluprost as compared to placebo in patients with normal tension glaucoma : randomized , double - blind , multicenter , phase III study", "", "<http://ctro/data#Publication_81108> <http://ctro/data#hasTitle> \"Intraocular pressure lowering effect of 0 . 0015 % tafluprost as compared to placebo in patients with normal tension glaucoma : randomized , double - blind , multicenter , phase III study\"."
2, IOP, 65, 85, "Intraocular pressure", "", "<http://ctro/data#IOP_81144> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_81143> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_81144>."
4, DoseValue, 105, 113, "0 . 0015", "", 
5, Percentage, 114, 115, "%", "", 
3, Tafluprost, 116, 126, "tafluprost", "", 
6, Placebo, 142, 149, "placebo", "", 
36998, NormalTensionGlaucoma, 167, 190, "normal tension glaucoma", "", "<http://ctro/data#ClinicalTrial_81116> <http://ctro/data#analysesHealthCondition> <http://ctro/data#NormalTensionGlaucoma>."
8, Randomized, 193, 203, "randomized", "", "<http://ctro/data#ClinicalTrial_81116> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
9, DoubleBlind, 206, 220, "double - blind", "", "<http://ctro/data#ClinicalTrial_81116> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
10, Multicenter, 223, 234, "multicenter", "", "<http://ctro/data#ClinicalTrial_81116> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
69, Author, 281, 291, "Kuwayama Y", "", "<http://ctro/data#Publication_81108> <http://ctro/data#hasAuthor> \"Kuwayama Y\"."
70, Author, 300, 311, "Komemushi S", "", "<http://ctro/data#Publication_81108> <http://ctro/data#hasAuthor> \"Komemushi S\"."
106, Tafluprost, 314, 324, "Tafluprost", "", 
12, Japan, 440, 445, "Japan", "", "<http://ctro/data#Population_81135> <http://ctro/data#hasCountry> <http://ctro/data#Japan>."
20, ObjectiveDescription, 458, 634, "To compare the efficacy and safety of 0 . 0015 % tafluprost ophthalmic solution ( Tafluprost ) with Placebo ophthalmic solution ( Placebo ) in normal tension glaucoma ( NTG ) .", "", "<http://ctro/data#ClinicalTrial_81116> <http://ctro/data#hasObjectiveDescription> \"To compare the efficacy and safety of 0 . 0015 % tafluprost ophthalmic solution ( Tafluprost ) with Placebo ophthalmic solution ( Placebo ) in normal tension glaucoma ( NTG ) .\"."
13, DoseValue, 496, 504, "0 . 0015", "", "<http://ctro/data#Medication_81178> <http://ctro/data#hasDoseValue> \"0 . 0015\"."
14, Percentage, 505, 506, "%", "", "<http://ctro/data#Medication_81178> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
15, Tafluprost, 507, 537, "tafluprost ophthalmic solution", "", "<http://ctro/data#Medication_81178> <http://ctro/data#hasDrug> <http://ctro/data#Tafluprost>."
16, Tafluprost, 540, 550, "Tafluprost", "", 
31864, Placebo, 558, 565, "Placebo", "", "<http://ctro/data#Medication_81185> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
18, Placebo, 588, 595, "Placebo", "", 
36999, NormalTensionGlaucoma, 601, 624, "normal tension glaucoma", "", 
37000, NormalTensionGlaucoma, 627, 630, "NTG", "", 
21, NumberPatientsCT, 654, 656, "94", "", "<http://ctro/data#ClinicalTrial_81116> <http://ctro/data#hasNumberPatientsCT> \"94\"."
22, Randomized, 680, 690, "randomized", "", 
23, DoubleBlind, 693, 707, "double - blind", "", 
24, Parallel, 710, 718, "parallel", "", "<http://ctro/data#ClinicalTrial_81116> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
25, Multicenter, 731, 742, "multicenter", "", 
37001, NormalTensionGlaucoma, 774, 777, "NTG", "", 
27, Randomized, 783, 791, "randomly", "", 
28, Tafluprost, 811, 821, "Tafluprost", "", 
29, Placebo, 825, 832, "Placebo", "", 
30, Frequency, 876, 886, "once a day", "", "<http://ctro/data#Intervention_81166> <http://ctro/data#hasFrequency> \"once a day\". <http://ctro/data#Intervention_81172> <http://ctro/data#hasFrequency> \"once a day\"."
82, Morning, 894, 901, "morning", "", "<http://ctro/data#Intervention_81166> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Morning>. <http://ctro/data#Intervention_81172> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Morning>."
32, Duration, 906, 913, "4 weeks", "", "<http://ctro/data#ClinicalTrial_81116> <http://ctro/data#hasCTduration> \"4 weeks\"."
33, Mean, 926, 930, "Mean", "", "<http://ctro/data#Mean_81145> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_81143> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_81145>."
34, IOP, 931, 951, "intraocular pressure", "", 
35, IOP, 954, 957, "IOP", "", 
87, Reduction, 989, 994, "4 . 0", "", "<http://ctro/data#Outcome_81192> <http://ctro/data#hasChangeValue> \"4 . 0\"."
37, SdDevChangeValue, 1001, 1006, "1 . 7", "", "<http://ctro/data#Outcome_81192> <http://ctro/data#hasSdDevChangeValue> \"1 . 7\"."
38, mmHg, 1007, 1011, "mmHg", "", "<http://ctro/data#Endpoint_81143> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
73, Tafluprost, 1015, 1025, "Tafluprost", "", 
90, Reduction, 1054, 1059, "1 . 4", "", "<http://ctro/data#Outcome_81219> <http://ctro/data#hasChangeValue> \"1 . 4\"."
40, SdDevChangeValue, 1066, 1071, "1 . 8", "", "<http://ctro/data#Outcome_81219> <http://ctro/data#hasSdDevChangeValue> \"1 . 8\"."
41, mmHg, 1072, 1076, "mmHg", "", 
42, Placebo, 1080, 1087, "Placebo", "", 
43, TimePoint, 1113, 1120, "4 weeks", "", "<http://ctro/data#Outcome_81192> <http://ctro/data#hasTimePoint> \"4 weeks\". <http://ctro/data#Outcome_81219> <http://ctro/data#hasTimePoint> \"4 weeks\"."
44, PvalueDiff, 1169, 1180, "p < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_81246> <http://ctro/data#hasPvalueDiff> \"p < 0 . 001\"."
45, IOP, 1185, 1188, "IOP", "", 
46, TimePoint, 1199, 1206, "4 weeks", "", 
47, IOP, 1211, 1214, "IOP", "", 
105, TimePoint, 1228, 1241, "2 and 4 weeks", "", 
36995, TimePoint, 1234, 1241, "4 weeks", "", 
48, Tafluprost, 1277, 1287, "Tafluprost", "", 
49, Placebo, 1296, 1303, "Placebo", "", 
31865, PercentageAffected, 1317, 1323, "51 . 0", "", "<http://ctro/data#Outcome_81260> <http://ctro/data#hasPercentageAffected> \"51 . 0\"."
52, Tafluprost, 1329, 1339, "Tafluprost", "", 
53, PercentageAffected, 1358, 1363, "8 . 9", "", "<http://ctro/data#Outcome_81287> <http://ctro/data#hasPercentageAffected> \"8 . 9\"."
54, Placebo, 1369, 1376, "Placebo", "", 
31867, EndPointDescription, 1400, 1422, "adverse drug reactions", "", "<http://ctro/data#EndPointDescription_81256> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_81255> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_81256>."
58, ConclusionComment, 1438, 1523, "These results indicate that Tafluprost is clinically useful in the treatment of NTG .", "", "<http://ctro/data#ClinicalTrial_81116> <http://ctro/data#hasConclusionComment> \"These results indicate that Tafluprost is clinically useful in the treatment of NTG .\"."
56, Tafluprost, 1466, 1476, "Tafluprost", "", 
36996, NormalTensionGlaucoma, 1518, 1521, "NTG", "", 
59, PMID, 1531, 1539, "20545217", "", "<http://ctro/data#Publication_81108> <http://ctro/data#hasPMID> \"20545217\"."
